Literature DB >> 2827746

Organization of the gene for human factor XI.

R Asakai1, E W Davie, D W Chung.   

Abstract

Factor XI (plasma thromboplastin antecedent) is a plasma glycoprotein that participates in the early phase of blood coagulation. The gene for the human protein has been isolated from two different lambda phage genomic libraries. Four independent recombinant lambda phage carrying overlapping DNA inserts that coded for the entire gene for factor XI were isolated and characterized by restriction mapping, Southern blotting, and selective DNA sequencing to establish the number and location of the intron-exon boundaries. The gene for human factor XI was 23 kilobases in length and consisted of 15 exons (I-XV) and 14 introns (A-N). Exon I coded for the 5' untranslated region, and exon II coded for the signal peptide. The next eight exons (III-X) coded for the four tandem repeats of 90 or 91 amino acids that were present in the amino-terminal region of the mature protein. Each of these tandem repeats was coded by two exons that were interrupted by a single intron, and these introns were located in essentially the same position within each of the four tandem repeats. The carboxyl-terminal region of the protein, which contained the catalytic chain, was coded by five exons (XI-XV) that were interrupted by four introns. The last four introns were located in the same positions as those in the genes for human tissue plasminogen activator and human urokinase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827746     DOI: 10.1021/bi00397a004

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Evidence against a protein in plasma that is a product of a factor XI mRNA splice variant missing exons 6 and 7.

Authors:  David Gailani; Mao-Fu Sun; Qiufang Cheng; Anton Matafonov; Erik I Tucker; Andras Gruber; Jonas Emsley
Journal:  Blood       Date:  2010-08-19       Impact factor: 22.113

2.  Factor XI (plasma thromboplastin antecedent) deficiency in Ashkenazi Jews is a bleeding disorder that can result from three types of point mutations.

Authors:  R Asakai; D W Chung; O D Ratnoff; E W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

3.  Dinucleotide repeat polymorphism in the human coagulation factor XI gene, intron B (F11), detected using the polymerase chain reaction.

Authors:  P Bodfish; D Warne; C Watkins; K Nyberg; N K Spurr
Journal:  Nucleic Acids Res       Date:  1991-12-25       Impact factor: 16.971

4.  A novel missense mutation Asp506Gly in Exon 13 of the F11 gene in an asymptomatic Korean woman with mild factor XI deficiency.

Authors:  Jong Ho Lee; Hee Soon Cho; Myung Soo Hyun; Hwa-Young Kim; Hee-Jin Kim
Journal:  Korean J Lab Med       Date:  2011-10-03

5.  RFLP for intron E of factor XI gene.

Authors:  M G Butler; A D Parsons
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

6.  Detection of single nucleotide polymorphisms in coagulation factor XI deficient patients by multitemperature single-strand conformation polymorphism analysis.

Authors:  Alexandra Bezak; Radosław Kaczanowski; Astrid Dossenbach-Glaninger; Krzysztof Kucharczyk; Werner Lubitz; Pierre Hopmeier
Journal:  J Clin Lab Anal       Date:  2005       Impact factor: 2.352

7.  A radiation hybrid map of 15 loci on the distal long arm of chromosome 4, the region containing the gene responsible for facioscapulohumeral muscular dystrophy (FSHD).

Authors:  S T Winokur; B Schutte; B Weiffenbach; S S Washington; D McElligott; A Chakravarti; J H Wasmuth; M R Altherr
Journal:  Am J Hum Genet       Date:  1993-10       Impact factor: 11.025

8.  12-year-old boy with a 4q35.2 microdeletion and involvement of MTNR1A, FAT1, and F11 genes.

Authors:  Erin L Youngs; Rebecca S Henkhaus; Jessica A Hellings; Merlin G Butler
Journal:  Clin Dysmorphol       Date:  2012-04       Impact factor: 0.816

9.  An insertion mutation of the bovine Fii gene is responsible for factor XI deficiency in Japanese black cattle.

Authors:  Masaki Kunieda; Takehito Tsuji; Abdol Rahim Abbasi; Maryam Khalaj; Miho Ikeda; Keiko Miyadera; Hiroyuki Ogawa; Tetsuo Kunieda
Journal:  Mamm Genome       Date:  2005-05       Impact factor: 2.957

10.  Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins.

Authors:  Boyangzi Li; Jiraporn Suwan; Jeffrey G Martin; Fuming Zhang; Zhenqing Zhang; Debra Hoppensteadt; Melanie Clark; Jawed Fareed; Robert J Linhardt
Journal:  Biochem Pharmacol       Date:  2009-04-21       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.